Navigation Links
Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Date:9/11/2012

0; You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or their negatives or cognates.  Such statements are valid only as of today, and we disclaim any obligation to update this information.  These statements are only estimates and predictions and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made.  These statements are based on our current beliefs and expectations as to such future outcomes.  Drug discovery and development involve a high degree of risk.  Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation, our  pharmaceutical collaborators' ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement.


'/>"/>
SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
11. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015  Holographic Optical Technologies of ... holographic medical imaging, is entering the world of consumer ... on April 20 th , 2015, the campaign will ... 8-inch and 22-inch displays will allow consumers to view ... time. In addition to the two displays, the company ...
(Date:3/27/2015)... 27, 2015 A new report from Kalorama Information ... – Chile , Colombia ... targets for IVD firms.  The healthcare research firm said that ... strategies for the Latin American continent with a population of ... supply operations. However, the country,s regional economic clout does not ...
(Date:3/27/2015)... , March 27, 2015 Report ... for leading ophthalmic drug companies  What does ... pharma ophthalmic industry ? Visiongain,s brand new report shows ... and prospects there. Our 242-page report provides ... areas in the industry and the future market prospects. ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... 8 Biopharmaceutical Company Kiadis Pharma announced today that ... application with the US Food and Drug Administration (FDA) to ... in the United States .  Kiadis Pharma is ... hospitals in Europe and Canada .  With ...
... ANNAPOLIS, Md. , July 8 ... company developing medical countermeasures against biological and chemical threats, ... in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine ... lyophilized rPA vaccine candidate is structurally stable and potent ...
Cached Medicine Technology:Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States 2Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States 3PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health 2PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health 3PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health 4PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health 5
(Date:3/29/2015)... Final Cut Pro X plugin ... Studios, entitled TranSports. , “TranSports is a compilation ... Pro X,” said Christiana Austin, CEO of Pixel Film ... effortlessly transition using this cool sports transition tool.” , ... styled transition pack for Final Cut Pro X. TranSports ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 “Health is ... “and as we learn more about the cannabinoid system ... March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ ... or endo-healing, is celebrated. Publius, of The Cannabis Papers: ... National Institutes of Health (PubMed) cannabinoid system (CS) articles ...
(Date:3/28/2015)... Coffee could not only perk you up in ... disease, researchers have found. , They found that those who ... antioxidants. Antioxidants fight gum disease. Does coffee, then, help fight ... Henry M. Goldman School of Dental Medicine explored in a ... the Journal of Periodontology. , “This is the first long-term ...
(Date:3/28/2015)... was featured on NewsWatch as part of its monthly ... coolest applications on the market for iOS, Android, and ... expert, conducted the app review and shared with viewers ... knights, nature, and peasants. , The first endless ... The popularity of these games grew over the years, ...
(Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2
... fire as healthcare workers,union informs residents, families that ... safety measures; Robert Greenwald,s Brave New,Films releases documentary ... July 7 Members of the Service,Employees International ... attention to ongoing safety concerns at leading assisted ...
... Scientists have identified a new antitumor drug that might ... cancers. The research, published by Cell Press in the ... , advances the understanding of one of the most ... provides new insight into the regulation of the complex ...
... Ind. - Panic, staffing issues and geographic boundaries are ... to address as they plan for a possible influenza ... , "Most public health experts who are leading planning ... geographic areas, usually counties, as defined by political lines," ...
... 7 VirtualHealth,Technologies, Inc. (OTC Bulletin Board: ... proven Real-Time Prescription Monitoring System announced,it,s support ... allow for the electronic,prescribing of controlled substances., ... proposed regulations,that would allow physicians to electronically ...
... been found to play a major role in,keeping the ... cells, MEMPHIS, Tenn., July 7 The lack ... enzyme that helps to,recycle molecules in cells causes an ... Jude Children,s Research Hospital investigators., Children with this ...
... inhibits abnormal cells, study finds , , MONDAY, July 7 ... and red wine suppresses abnormal cell formation that leads ... researchers. , The compound, resveratrol, is sold in extract ... through a multi-stage process that differs depending on the ...
Cached Medicine News:Health News:Exploitation of Residents at Wasserstein and Lazard-linked Senior Care Facilities Exposed 2Health News:Bacterial peptide provides new insight into common tumor suppressor 2Health News:Political borders, health-care issues complicate pandemic planning 2Health News:Political borders, health-care issues complicate pandemic planning 3Health News:E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward Reality 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 3Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 4Health News:Dietary Supplement May Prevent Breast Cancer 2
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: